Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying

Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying. For our methodology and a more comprehensive list, go directly to Top 10 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying.

5. SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)

Closing out the first half of our list of Sphera Global’s big stock buys of Q3 is SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), which the fund bought 52,800 shares of during the quarter, building its stake in the company to 247,917 shares in the process, a position valued at $15.73 million on September 30.

The amount of shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) that are collectively owned by the group of hedge funds tracked by Insider Monkey has declined in each of the past five quarters, though by a modest amount each time. Those declines were frequently the result of prominent shareholder OrbiMed Advisors trimming its position.

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) has announced several developments over the past two months, including a new partnership with pharmaceutical giant AbbVie Inc (NYSE:ABBV) that will see the latter foot the bill for a collaborative clinical trial that will utilize that company’s ABBV-383 in combination with SpringWorks’ gamma-secretase inhibitor for the treatment of relapsed or refractory multiple myeloma. SpringWorks also announced the dosing of the first patient in its Phase 1b/2 trial of nirogacestat.

To see which other healthcare stocks Sphera Global was buying instead of some of its other current or former holdings like Merck & Co., Inc. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), and Perrigo Co Plc (NASDAQ:PRGO), check out the conclusion of this article linked to below.